InsidersTradesSigma
Total declarations
Company
▲ Purchases (6 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
6
Disclosed sells
0
T+90 hit rate
67%
T+90 mean return
-0.8%
Across 6 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the complete record of transactions filed by Hecht Peter M, Chief Executive Officer. Officer active across 1 company, notably Cyclerion Therapeutics, Inc.. Aggregated, 10 filings have been recorded. Split: 6 buys · 0 sell. Total volume traded: €6.2m. Activity tracked since 4 May 2021. The latest transaction was filed on 25 March 2025 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations10 total
181,818 shares@ US$2.755.4% of flowCommon StockSEC:0000950170-25-046280:0
15,000 shares0Common StockSEC:0000950170-24-007920:0
20,000 shares0Common StockSEC:0000950170-23-067738:0
225,000 shares@ US$8.6821.3% of flowCommon StockSEC:0001140361-23-026101:0
823,170 shares@ US$3.2826.1% of flowCommon StockSEC:0001140361-21-020090
Ideal exit: 28 Feb 2022 (T+270)
823,170 shares@ US$3.2846.04% mcap35.7% of flowCommon StockSEC:0001140361-21-020090:0
Ideal exit: 28 Feb 2022 (T+270)
302,000 shares@ US$2.4312.58% mcap9.7% of flowCommon StockSEC:0001140361-21-016532:0
Ideal exit: 31 Jan 2022 (T+270)
302,000 shares@ US$2.439.7% of flowCommon StockSEC:0001140361-21-016532
Ideal exit: 31 Jan 2022 (T+270)
300,000 sharesCommon StockSEC:0001140361-21-016304
Ideal exit: 29 Jan 2022 (T+270)
300,000 shares@ US$2.2911.83% mcap9.2% of flowCommon StockSEC:0001140361-21-016304:0
Ideal exit: 29 Jan 2022 (T+270)
10 of 10 declarations
About Hecht Peter M
Hecht Peter M is the Chief Executive Officer of Cyclerion Therapeutics, Inc. In this role, he is responsible for the strategic direction of the company and the management of its operations. His leadership is essential in guiding the organization toward its goals, ensuring it remains competitive and innovative in the biotechnology sector.
